<?xml-stylesheet type="text/xsl" href="https://community.cadence.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Accelerating Drug Discovery with Agentic AI and Computational Science</title><link>/cadence_blogs_8/b/corporate-news/posts/accelerating-drug-discovery-with-agentic-ai-and-computational-science</link><description>By Louis Culot, corporate vice president and general manager, Cadence Molecular Sciences (OpenEye)
We recently discussed the rise of the autonomous engineer &amp;mdash;the transition from human-driven to human-supervised workflows in semiconductor design ...</description><dc:language>en-US</dc:language><generator>Telligent Community 12</generator></channel></rss>